Dr Ayazullah Safi | Health Professions | Best Research Article Award

Dr Ayazullah Safi | Health Professions | Best Research Article Award

Dr Dr Ayazullah Safi, Birmingham City University, United Kingdom

Dr. Ayazullah Safi is a Senior Lecturer in the Department of Public Health at Birmingham City University, UK. With a dynamic career in teaching, research, and leadership, he specializes in health promotion, public health, physical activity, and nutrition. Dr. Safi has played pivotal roles in curriculum development, student supervision, and international research collaborations. He is also the founder of Anywhere Active, a platform that promotes physical wellbeing and community engagement. His academic journey is marked by innovative contributions across multiple education sectors, including higher education, secondary education, and community outreach. A committed mentor and educator, Dr. Safi is known for his ability to integrate theory with practical impact, particularly for underrepresented and vulnerable populations. His national and international recognition stems from his extensive research outputs, competitive grant success, and public health advocacy. Passionate about improving lives through education and evidence-based practices, Dr. Safi continues to inspire students, peers, and communities alike.

Publication Profile

orcid

Education

Dr. Safi earned his PhD in Public Health with a dissertation focused on workplace physical activity interventions and their impact on university employees’ health and wellbeing. He also holds a Master of Arts in Sport Studies and Physical Education, and a Bachelor of Arts in Sport Studies. In pursuit of teaching excellence, he obtained a Postgraduate Certificate in Research Practice in Higher Education, a Senior Fellowship from Advance HE, and completed an Academic Professional Apprenticeship. Additionally, he achieved the SEDA (Staff and Educational Development Association) Recognised Supervisor status, demonstrating his capability in mentoring and supervising academic research. Dr. Safi’s educational background reflects a strong commitment to advancing health sciences and pedagogy. His multi-disciplinary foundation empowers him to teach and lead across undergraduate, postgraduate, and foundation-level programmes with a rich understanding of both the scientific and sociocultural determinants of health, nutrition, and behaviour change.

Experience

Dr. Ayazullah Safi has accumulated over a decade of experience across public health, sports science, and education. He is currently a Senior Lecturer at Birmingham City University, where he serves as Deputy Course Leader for the MPH programme and leads multiple public health modules. Previously, he was a Lecturer and Course Leader for the MSc in Sport and Exercise Nutrition at the University of Westminster. His teaching spans undergraduate to postgraduate levels, with leadership in curriculum design, validation, and student supervision. He has also worked as a Consultant and Lecturer for the Workers’ Education Association, a Citizenship Teacher and Head of PE at Darul Uloom High School, and as the Director of community health initiatives such as Safi’s Sports and Fitness and Anywhere Active. His interdisciplinary experience in academia, community outreach, and project leadership reflects a well-rounded and impactful professional trajectory in promoting health and wellbeing through education and evidence-based practice.

Awards and Honors

Dr. Safi’s commitment to excellence in teaching, research, and community service has been widely recognised. In 2024/25, Birmingham City University was shortlisted for the prestigious Sir Lenny Henry Inclusivity Award under his leadership. He received Highly Commended distinctions for both Inspirational Teacher of the Year and Research Supervisor of the Year in 2023/24. In 2022, he was named a Role Model for Under-Represented Communities by the British Association of Sport and Exercise Sciences (BASES). His earlier accolades include the Contribution to the Community Award from the Youth Development Association in Afghanistan (2020), Research of the Year at Birmingham City University (2018/19), and Poster Presentation Prize Winner at the British Psychological Society (BPS) Annual Conference in 2019. These awards affirm Dr. Safi’s dedication to inclusive education, impactful research, and community wellbeing, marking him as an influential figure in both academic and grassroots health environments.

Research Focus

Dr. Ayazullah Safi’s research focuses on promoting health and wellbeing through physical activity, nutrition, and behaviour change strategies. His PhD examined the effects of workplace physical activity interventions on employee health and lifestyle transformation. He is particularly interested in interdisciplinary approaches that integrate public health, sports science, and leadership to address sedentary lifestyles, chronic disease prevention, and health inequalities. His work often targets underrepresented communities, promoting culturally sensitive, community-based health solutions. Dr. Safi has led and contributed to several funded research projects, including those on adolescent health in Saudi Arabia, healthy fan zones during Eurovision, and NHS health check focus groups. He is currently involved in multimorbidity prevention projects among BAME populations. By bridging academic theory and real-world application, his research supports both local and international public health initiatives, while fostering global academic collaborations and student-led investigations.

Publication Top Notes

  • 🧠 “Workplace Interventions and Wellbeing: A Meta-Analysis of University Staff Health” – Public Health Journal

  • 🏋️‍♂️ “Physical Activity Patterns Among UK Office Workers Post-COVID-19” – Journal of Exercise Science

  • 🍎 “Precision Nutrition in Community Health Programmes” – Global Nutrition Insights

  • 🌍 “Decolonising Health Curricula: Challenges and Strategies” – Education and Society

  • 💬 “Community Voices: Evaluating NHS Health Checks through Focus Groups” – Health Policy and Planning

Firas Abdollah | Medicine and Dentistry | Best Researcher Award

Firas Abdollah | Medicine and Dentistry | Best Researcher Award

Dr Firas Abdollah,Henry Ford Health,United States

Dr. Firas Abdollah is a Clinical Associate Professor and Vice-Chair of Academic and Research at the Vattikuti Urology Institute, Henry Ford Hospital. With dual citizenship in the USA and Italy, he has a distinguished career in urologic oncology and robotic surgery. He specializes in the epidemiology of urologic cancers and the development of predictive tools for cancer outcomes. He has held research and faculty positions at leading institutions, including Wayne State University and Michigan State University. His extensive contributions to urology have earned him numerous awards, and his research has been published in top-tier journals. Dr. Abdollah is also a medical consultant for Intuitive Surgical Inc.

Publication Profile

Orcid

Education

Dr Firas Abdollah began his academic journey at Al Mutamayizeen Secondary School in Baghdad, Iraq, where he completed his Bachelor of Science between 1995 and 1997. He then pursued a Doctor of Medicine degree at the College of Medicine, Baghdad University, graduating in 2003. Following his medical education, he underwent extensive training through internships and residency at San-Raffaele Hospital, University Vita-Salute, in Milan, Italy, from 2004 to 2012. Further advancing his expertise, he completed a prestigious Fellowship in Robotic Urologic Oncology at the Henry Ford Hospital, Vattikuti Urology Institute, in Detroit, Michigan, USA, from 2015 to 2018.

Experience

Associate Professor at Wayne State University, a position he has held since 2020, and also serves as Vice-Chair of Academic and Research at the Vattikuti Urology Institute, Henry Ford Hospital. In addition, he has been a Clinical Associate Professor at Michigan State University since 2022. His extensive experience in medical consulting includes his current role at Intuitive Surgical Inc., California, starting in 2024. Previously, he was a Medical Consultant for the Department of Urology at the Academic Hospital San Raffaele in Milan, Italy, from 2011 to 2013, and served as a Medical Consultant and Advisor for GenomeDx Biosciences in Vancouver, Canada, from 2014 to 2020. His collaboration with KOELIS Inc. in Delaware lasted from 2022 to 2024 through a consulting and research agreement. Dr. [Name] has also been actively involved in research, having worked as a Research Investigator at Henry Ford Hospital, focusing on prognostic models for prostate and bladder cancers from 2014 to 2015. Earlier in his career, he contributed to cancer prognostics and health outcomes research at the University of Montreal in 2010.

Awards & Honors

  • Best Poster Award – Società Italiana di Urologia Annual Congress (2007)
  • Best of AUA/JUA Meeting Award – AUA Annual Meeting, Washington DC (2011)
  • Best Paper – European Urology Resident Corner (2012)
  • Best Poster Award – European Association of Urology Congress (2012, 2013, 2014, 2018)
  • Excellence in Research Award – Southeast Michigan Center for Medical Education (2017)
  • Top 1% in Field for Peer Reviews – Publons (2017)
  • First Place, Fellow Clinical Research – European Association of Urology Congress (2018)

 

Research Focus

  • Epidemiology of Urologic-Oncology Diseases
  • Prostate, Kidney, Bladder, Testicular, and Penile Cancers
  • Development of Prediction Tools for Disease-Specific Mortality and Recurrence
  • Robotic Urologic Oncology and Outcomes Resear

 

Publication
  • 📖 The importance of pelvic lymph node dissection in the elderly: Implications for interpretation of NCCN guidelines
  • 📖 A novel tool for predicting urinary incontinence after radical prostatectomy
  • 📖 Competing risks analysis of long-term survival in node-positive prostate cancer
  • 📖 Predicting pathological outcomes in patients undergoing robot-assisted radical prostatectomy
  • 📖 Testing the impact of adjuvant radiotherapy on overall mortality in prostate cancer patients
  • 📖 External validity of EORTC 30904 in North American patients with renal cell carcinoma